As the market for GLP-1 injections continues to grow, BD aims to ride that wave by providing drugmakers with its prefilled syringes. Biologic medications—including those blockbusters for diabetes and ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced the successful completion of a joint feasibility ...

FRANKLIN LAKES, N.J. and SAN DIEGO, Jan. 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of laboratory ...

BD and Envetec prove medical plastic waste can be safely recycled into new products reducing landfill dependency ...

Yesterday, Becton, Dickinson and Company BDX, popularly known as BD, announced a collaboration with ChemoGLO, a notable name in hazardous drug detection and decontamination. The partnership is aimed ...

FRANKLIN LAKES, N.J., Sept. 22, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a pharmacy automation partnership with ...

BD announced the general release of its Pyxis ES System, a scalable, web–accessible platform designed to improve medication management. The system is comprised of the Pyxis Enterprise Server, Pyxis ...

The new 5.5ml BD Neopak XtraFlow Syringe uses BD’s advanced technologies, including thinner cannulas.

FRANKLIN LAKES, N.J., Dec. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and ChemoGLO™, a specialist in hazardous drug detection ...

Becton, Dickinson and Co. plans to invest more than $35 million to expand a prefilled flush syringe manufacturing facility in Nebraska to better meet growing demand from U.S. hospitals and health care ...